Preliminary scientific tests reveal conolidine could inhibit certain ion channels, lowering neuronal excitability and restricting agony alerts. This system is especially relevant in neuropathic suffering, exactly where irregular signaling will cause persistent pain. Furthermore, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to discomfort perception. ... https://gracem245hat1.bmswiki.com/user